SUIT-017 O2 pfi D049

From Bioblast
Jump to: navigation, search
Bioblasts - Richard Altmann and MiPArt by Odra Noel
MitoPedia         Terms and abbreviations         Concepts and methods         Oroboros O2k         MiP and biochemistry         Preprints and history



MitoPedia

SUIT-017 O2 pfi D049

Description

1OctM;2D;2c;3G;4S;5U;6Rot;7Ama.png

Abbreviation: FNS(Oct,GM)

Reference: A: SUIT-017

SUIT number: D049_1OctM;2D;2c;3G;4S;5U;6Rot;7Ama

O2k-Application: O2

MitoPedia: SUIT
SUIT-category: FNS(Oct,GM)
SUIT protocol pattern: diametral 1OctM;2D;2c;3G;4S;5U;6Rot-

SUIT-017 O2 pfi D049 gives information on F-pathway in LEAK state and OXPHOS state avoiding FAO overestimation in the presence of anaplerotic pathways. In addition, the pathway control of FN and FNS in OXPHOS state and of FNS and S in ET state is evaluated.

Communicated by Cardoso LH and Gnaiger E (last update 2019-02-26)
MitoPedia: SUIT

Steps and respiratory states

1OctM;2D;3G;4S;5U;6Rot;7Ama.png

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1OctM OctML(n) F(N) FAO 1OctM

Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. Low concentration of malate, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. Non-phosphorylating resting state (LEAK state); LEAK-respiration, L(n), in the absence of ADP, ATP, AMP (no adenylates).

2D OctMP F(N) FAO 1OctM;2D

Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. Low concentration of malate, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. OXPHOS capacity, P (with saturating [ADP]), active OXPHOS state.

3G OctGMP FN F&CI 1OctM;2D;3G

NADH-linked substrates (type N-pathway to Q). Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. OXPHOS capacity, P (with saturating [ADP]), active OXPHOS state.

4S OctGMSP FNS F&CI&II 1OctM;2D;3G;4S

Respiratory stimulation by simultaneous action of type N substrates & succinate, with convergent electron flow in the NS-pathway for reconstitution of TCA cycle function. Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. OXPHOS capacity, P (with saturating [ADP]), active OXPHOS state.

5U OctGMSE FNS F&CI&II 1OctM;2D;3G;4S;5U

Respiratory stimulation by simultaneous action of type N substrates & succinate, with convergent electron flow in the NS-pathway for reconstitution of TCA cycle function. Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. Noncoupled electron transfer state, ET-state, with ET-capacity, E.

6Rot SE S CII 1OctM;2D;3G;4S;5U;6Rot

Succinate pathway control state (S-pathway) after inhibiting CI with rotenone, which also inhibits the F-pathway if fatty acids are present. Noncoupled electron transfer state, ET-state, with ET-capacity, E.

7Ama ROX 1OctM;2D;3G;4S;5U;6Rot;7Ama

Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.

Step Respiratory state Pathway control ET-Complex entry into Q-junction Comment
## Tm TmE CIV CIV
## Azd ROX


Questions.jpg


Click to expand or collaps

Strengths and limitations

  • Comparison of GM- with PM-capacity yields important information on N-pathway respiratory control upstream of CI (Lemieux et al. 2017; Votion et al. 2012).
+ Glutamate is easier to prepare compared to pyruvate.
+ Reasonable duration of the experiment.
+ This protocol can be extended with the Complex IV module, which can prolong the experimental time with ~30 min.

Compare SUIT protocols

  • SUIT-002: A more comprehensive protocol incuding additional substrate states.
  • SUIT-005: A comparable protocol evaluating P instead of G.

References

 YearReferenceOrganismTissue;cell
Pesta 2012 Methods Mol Biol2012
O2k-Protocols
Pesta D, Gnaiger E (2012) High-resolution respirometry. OXPHOS protocols for human cells and permeabilized fibres from small biopsies of human muscle. Methods Mol Biol 810:25-58.
HumanFibroblast
HEK
HUVEC
Other cell lines
Skeletal muscle


MitoPedia concepts: SUIT protocol, SUIT A, Find 


MitoPedia methods: Respirometry